New dengue drug shows promise in clinical trial
NCT ID NCT07576868
First seen May 13, 2026 · Last updated May 13, 2026
Summary
This study tests an experimental drug called CP-COV03 in adults with dengue fever. The goal is to see if it safely reduces the virus and speeds up symptom recovery. About 210 participants will receive either the drug or a placebo. The trial is currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The National Hospital of Tropical Diseases (NHTD)
NOT_YET_RECRUITINGHanoi, Vietnam
-
Tien Giang Provincial General Hospital
RECRUITINGMỹ Tho, Vietnam
Conditions
Explore the condition pages connected to this study.